Related Experiment Video
Updated: Aug 15, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
[Virology of hepatitis C virus]
1Klinisches Institut für Virologie, Universität Wien, Kinderspitalgasse 15, A-1095 Wien. virologie@univie.ac.at
Insights
Hepatitis C virus (HCV) is a highly variable virus with implications for treatment. Inhibiting the NS3 protein offers a promising therapeutic strategy for managing HCV infection.
Area of Science:
- Virology
- Molecular Biology
Context:
- Hepatitis C virus (HCV) belongs to the hepacivirus genus within the Flaviviridae family.
- HCV possesses a single open reading frame (ORF) encoding a polyprotein precursor.
Purpose:
- To highlight the structural and functional significance of the NS3 protein in HCV replication.
- To explore therapeutic strategies targeting NS3 function for Hepatitis C treatment.
Summary:
- The HCV polyprotein is proteolytically processed into structural and non-structural proteins, with the NS3 protein playing a crucial role.
- HCV exhibits significant genetic variability, leading to quasispecies within infected individuals and classification into distinct genotypes and subtypes.
- The variability of HCV impacts epidemiological, biological, and therapeutic considerations.
Impact:
- Inhibition of NS3 function presents a promising therapeutic avenue for Hepatitis C treatment.
- Understanding HCV genotypes and subtypes is crucial for effective epidemiological tracking and personalized therapeutic approaches.
Abstract:
Hepatitis C virus (HCV) along with hepatitis G virus are members of the hepacivirus genus of the flavi-viridae family to which the flavi- and pestis viruses also belong. The HCV genome has only one ORF which is flanked by a 5' and 3' noncoding region. The ORF encodes for a single polyprotein, which is stepwise cleaved into the 3 structural proteins, core (C), envelope 1 and 2 (E1,2) as well as into 7 non-structural proteins (p7, NS2, NS3, NS4A, NS4B, NS5A, NS5B). The proteolytic active NS3 plays a central role in this processing. Whereas expectations for development of an HCV vaccine are not very optimistic today, there is great hope in new therapeutic possibilities by inhibition of NS3 function. HCV is highly variable. In the liver and serum of a single patient, genetically slightly different virus particles (quasispecies) can be found. Worldwide, hepatitis C virus has been classified into genotypes and subtypes. This differentiation is not only important epidemiologically, but also has biological and therapeutical implications.
Related Concept Videos
Retrovirus Life Cycles
Viruses with RNA Genomes
Cytomegalovirus Disease
Hepatitis
Inhibitors Of Virion Release
Viral Hepatitis I: Introduction

